Stony Brook Appoints Dermatologist Specializing in Latest Skin Cancer Surgical Techniques
With skin cancer on the rise, Dr. Jordan Slutsky, a Long Island native and Stony Brook Medicine alumnus, broadens the scope of treatments for patients
According to the American Academy of Dermatology (AAD), skin cancer rates continue to rise. The rates of melanoma, one of the most dangerous forms of skin cancer, have increased more than 2 percent per year for approximately 30 years. Regionally, this translates to thousands of Long Islanders annually who develop skin cancer. The AAD currently estimates that one in five Americans will develop skin cancer in their lifetime.
Board certified in Dermatology and fellowship trained in Mohs surgery, Dr. Slutsky, a Long Island native from Bellmore, returns to Stony Brook where he graduated from Stony Brook University School of Medicine in 2007. After completing a one-year Internal Medicine residency at Winthrop University Hospital, he entered a three-year Dermatology residency at Stony Brook where he rose to Chief Resident in 2011.
With a practice that focuses on early detection and diagnosis of cutaneous malignancies including basal cell carcinoma (BCC), squamous cell carcinoma (SCC), melanoma, and other less common skin tumors, Dr. Slutsky takes a multidisciplinary treatment and management approach with his Stony Brook Medicine colleagues that include surgical as well as topical, photodynamic and oral therapies for skin cancer. He also has extensive experience treating high-risk, immunocompromised and organ transplant patients with skin cancer.
“Dr. Slutsky’s expertise broadens our Division of Mohs Surgery scope of surgical offerings to provide the best options for all patients with skin cancer,” said Dr. Jones. “His advanced surgical training and expertise in both conservative and radical treatments of malignant skin tumors makes him a distinct addition to our Department.”
Dr. Slutsky comes to Stony Brook from St. Louis University Hospital where he completed a two-year Fellowship in Mohs Micrographic Surgery & Cutaneous Oncology, under the direction of Dr. Scott Fosko, President of the American College of Mohs Surgery (ACMS). Mohs surgery is a specialized procedure that removes skin tumor tissue layer by layer to ensure the entire tumor is removed. At Stony Brook, Dr. Slutsky will perform Mohs surgery and an emerging variation of the method called Slow Mohs that offers the high cure rate and normal tissue sparing advantages of standard Mohs but more effective for lentiginous melanoma, unusual and high-risk cutaneous tumors. Slow Mohs is carried out in stages rather than by a single surgery because the tissue is difficult to analyze using the frozen tissue sections effective in standard Mohs surgery.
Dr. Jones said Dr. Slutsky’s additional surgical expertise expands the cosmetic and reconstructive dermatology team’s offerings to patients. He will perform various minimally invasive procedures including dermal fillers, toxins (i.e, Botox), sclerotherapy for the treatment leg veins, and laser procedures using the Department’s multiple laser technologies.
Dr. Slutsky’s research interests include investigations of treatment approaches to metastatic cutaneous SCC, complications in cutaneous surgery, early skin cancer detection, and the treatment effectiveness and safety outcomes in patients with skin cancer.
Dr. Slutsky is a fellow of the American Academy of Dermatology (AAD) and American Board of Dermatology. He is also a member of the American Medical Association, American Society for Dermatologic Surgery (ASDS), Women’s Dermatologic Society, and the ACMS.
Active as a national speaker with the ASDS, Dr. Slutsky lectures on cutaneous surgery techniques such as Slow Mohs and other cutting-edge procedures for skin cancer and reconstructive surgery.
Dr. Slutsky has contributed to dermatologic literature with studies published in the Archives of Dermatology, Dermatologic Surgery, Journal of Drugs in Dermatology and other journals. As a Dermatology resident at Stony Brook, he was recognized by the Department in 2011 with the Dermatology Research Award for his “significant contributions to the medical literature during residency.”
In 2012 he was named the AAD Association’s Advocate of the Year.
© Stony Brook University 2013